Brief: Innovative Pharmaceutical Biotech enters subscription agreements
March 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd 0399.HK : * The company entered into the subscription agreements with the subscribers * Subscribers agreed to subscribe for the convertible bonds in the aggregate principal amount of hk$280 million * Net proceeds from the issue of the convertible bonds estimated to be approximately hk$279 million * Source text for Eikon ID:nHKS1BjW3N * ((For more news, please click here 0399.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU